Bicara Therapeutics Inc. SEC filings

Filings

1. SCHEDULE 13G/ABicara Therapeutics Inc.BCAXOct 8

   Bicara Therapeutics Inc. (BCAX) reports 4.2% stake

   • T. Rowe Price Investment Management, Inc. holds 2,804,772 shares
   • 4.2% of the class is beneficially owned
   • Sole voting power is 2,798,430 shares

   T. Rowe Price Investment Management, Inc., filed by

2. 4Bicara Therapeutics Inc.BCAXSep 10

   Ryan Cohlhepp, insider filing for BCAX

   Ryan Cohlhepp, reporting

3. 144Bicara Therapeutics Inc.BCAXSep 8

   2 Form 144 notices

   Ivan Hyep, planned sale of BCAX shares

   Show all 2

   • 144Planned insider sale of BCAX sharesSep 8
   • 144Planned insider sale of BCAX sharesSep 8

   Ivan Hyep, reporting

4. 8-KBicara Therapeutics Inc.BCAXAug 25

   Current report

5. 4Bicara Therapeutics Inc.BCAXAug 14

   2 insider filings

   Jennifer Larson, insider filing for BCAX

   Show all 2

   • 4Insider filing for BCAXAug 14
   • 3New insider at BCAXAug 14

   Jennifer Larson, reporting

6. SCHEDULE 13G/ABicara Therapeutics Inc.BCAXAug 13

   Ownership stake disclosure by Janus Henderson Group Ltd. (amended)

   Janus Henderson Group Ltd., filed by

7. 4Bicara Therapeutics Inc.BCAXAug 12

   3 insider filings

   Claire Mazumdar, insider filing for BCAX

   Show all 3

   • 4Insider filing for BCAXAug 12
   • 4Insider filing for BCAXAug 12
   • 4Insider filing for BCAXAug 12

   Claire Mazumdar, reporting

8. S-8Bicara Therapeutics Inc.BCAXAug 11

   Employee stock plan registration

9. 10-QBicara Therapeutics Inc.BCAXAug 11

   Quarterly report

10. 8-KBicara Therapeutics Inc.BCAXAug 11

    Current report

11. 144Bicara Therapeutics Inc.BCAXAug 10

    3 Form 144 notices

    Ivan Hyep, planned sale of BCAX shares

    Show all 3

    • 144Planned insider sale of BCAX sharesAug 10
    • 144Planned insider sale of BCAX sharesAug 10
    • 144Planned insider sale of BCAX sharesAug 10

    Ivan Hyep, reporting

12. 4Bicara Therapeutics Inc.BCAXJul 29

    4 insider filings

    Jeremy Bender, insider filing for BCAX

    Show all 4

    • 4Insider filing for BCAXJul 29
    • 4Insider filing for BCAXJul 29
    • 3New insider at BCAXJul 29
    • 3New insider at BCAXJul 29

    Jeremy Bender, reporting

13. 8-KBicara Therapeutics Inc.BCAXJul 28

    Current report

14. SCHEDULE 13GBicara Therapeutics Inc.BCAXJul 27

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

15. 4Bicara Therapeutics Inc.BCAXJul 14

    Claire Mazumdar, insider filing for BCAX

    Claire Mazumdar, reporting

16. 4Bicara Therapeutics Inc.BCAXJul 10

    2 insider filings

    Ryan Cohlhepp, insider filing for BCAX

    Show all 2

    • 4Insider filing for BCAXJul 10
    • 4Insider filing for BCAXJul 10

    Ryan Cohlhepp, reporting

17. 144Bicara Therapeutics Inc.BCAXJul 10

    Claire Mazumdar, planned sale of BCAX shares

    Claire Mazumdar, reporting

18. 144Bicara Therapeutics Inc.BCAXJul 8

    3 Form 144 notices

    David Raben, planned sale of BCAX shares

    Show all 3

    • 144Planned insider sale of BCAX sharesJul 8
    • 144Planned insider sale of BCAX sharesJul 8
    • 144Planned insider sale of BCAX sharesJul 8

    David Raben, reporting

19. 144Bicara Therapeutics Inc.BCAXJul 7

    Lara Meisner, planned sale of BCAX shares

    Lara Meisner, reporting

20. 144Bicara Therapeutics Inc.BCAXJun 25

    David Raben, planned sale of BCAX shares

    David Raben, reporting

21. 4Bicara Therapeutics Inc.BCAXJun 10

    7 insider filings

    RA Capital Healthcare Fund LP, insider filing for BCAX

    Show all 7

    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10
    • 4Insider filing for BCAXJun 10

    RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +3 more

22. 8-KBicara Therapeutics Inc.BCAXJun 10

    Current report

23. 144Bicara Therapeutics Inc.BCAXJun 1

    Lara Meisner, planned sale of BCAX shares

    Lara Meisner, reporting

24. 4Bicara Therapeutics Inc.BCAXMay 26

    Ivan Hyep, insider filing for BCAX

    Ivan Hyep, reporting

25. 144Bicara Therapeutics Inc.BCAXMay 26

    David Raben, planned sale of BCAX shares

    David Raben, reporting

26. 8-KBicara Therapeutics Inc.BCAXMay 21

    Current report

27. 144Bicara Therapeutics Inc.BCAXMay 21

    Ivan Hyep, planned sale of BCAX shares

    Ivan Hyep, reporting

28. 4Bicara Therapeutics Inc.BCAXMay 20

    Claire Mazumdar, insider filing for BCAX

    Claire Mazumdar, reporting

29. 4Bicara Therapeutics Inc.BCAXMay 18

    Ryan Cohlhepp, insider filing for BCAX

    Ryan Cohlhepp, reporting

30. 144Bicara Therapeutics Inc.BCAXMay 18

    Claire Mazumdar, planned sale of BCAX shares

    Claire Mazumdar, reporting

31. SCHEDULE 13G/ABicara Therapeutics Inc.BCAXMay 15

    Ownership stake disclosure by Vestal Point Capital, LP (amended)

    Vestal Point Capital, LP, filed by

32. 144Bicara Therapeutics Inc.BCAXMay 15

    Ryan Cohlhepp, planned sale of BCAX shares

    Ryan Cohlhepp, reporting

Older filings on EDGAR